NASDAQ:POAI Predictive Oncology Q2 2025 Earnings Results & Report $8.41 -0.19 (-2.21%) As of 10/15/2026 Predictive Oncology missed analyst expectations on both earnings and revenue in its Q2 2025 results, released August 13, 2025. The company reported EPS of -$3.30 versus the -$1.35 consensus estimate, while revenue of $0.00 million fell short of the $1.50 million estimate by $1.50 million. Research:ProfileEarnings History Earnings Announcement Details QuarterQ2 2025Report DateAugust 13, 2025TimeBefore Market OpensConference Call DateAugust 14, 2025Conference Call7:00 AM ET Predictive Oncology EPS ResultsActual EPS-$3.30Consensus EPS -$1.35Beat/MissMissed by -$1.95One Year Ago EPSN/AEPS Beat Rate0 of last 6 quartersPredictive Oncology Revenue ResultsActual Revenue$0.00 millionExpected Revenue$1.50 millionBeat/MissMissed by -$1.50 millionYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Predictive Oncology Q2 2025 Earnings FAQ Did Predictive Oncology beat earnings estimates for Q2 2025? Predictive Oncology (NASDAQ:POAI) reported earnings of -$3.30 per share for Q2 2025, missing the consensus estimate of -$1.35. The report was announced on Wednesday, August 13, 2025. What was Predictive Oncology's revenue for Q2 2025? Predictive Oncology reported revenue of $0.00 million for Q2 2025, against a consensus estimate of $1.50 million. Predictive Oncology Earnings HeadlinesPredictive Oncology (NASDAQ:POAI) Shares Cross Above 50-Day Moving Average - What's Next?October 6, 2026 | americanbankingnews.comPredictive Oncology announces name change to Axe ComputeDecember 12, 2025 | msn.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.October 16 at 1:00 AM | Porter & Company (Ad)Predictive Oncology rebrands to Axe Compute Inc.December 11, 2025 | msn.comPredictive Oncology Regains Nasdaq ComplianceDecember 2, 2025 | tipranks.comPredictive Oncology regains compliance with Nasdaq minimum stockholder equityDecember 2, 2025 | msn.comSee More Predictive Oncology Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Predictive Oncology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Predictive Oncology and other key companies, straight to your email. Email Address About Predictive OncologyPredictive Oncology (NASDAQ:POAI) (NASDAQ: POAI) is a biotechnology company focused on applying artificial intelligence and machine learning to oncology drug discovery and precision medicine. The company combines computational tools with biological data to help identify promising therapeutic candidates and predict how individual tumors may respond to specific treatments. Its technology platform is built around a proprietary collection of tumor samples and associated clinical and drug-response information. Predictive Oncology uses this data to support pharmaceutical and biotechnology companies in evaluating drug candidates, identifying potential biomarkers, and developing more targeted cancer therapies. The company has also offered tumor-profiling and drug-response testing through its Helomics subsidiary and related operations. Predictive Oncology’s business has evolved from earlier precision-medicine and cancer-diagnostics activities toward an artificial-intelligence-driven drug discovery model. Its operations and research collaborations have been based primarily in the United States, although the company’s platform is intended to support pharmaceutical and biotechnology partners more broadly. Specific details about its current leadership structure and geographic commercial reach may change over time.View Predictive Oncology ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Bank of America Stock Sell-Off Looks Like a Buying OpportunityMorgan Stanley Beats on Earnings, But Shares Fall on Trading MixFundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?Palantir's Potential Next Catalyst After Retail Profit-TakingApple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure Upcoming Earnings HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
